AbbVie (ABBV) Change in Cash (2012 - 2026)

AbbVie (ABBV) has 15 years of Change in Cash data on file, last reported at $4.2 billion in Q1 2026.

• Change in Cash for Q1 2026 came in at $4.2 billion, up 1292.55% year-over-year; the trailing twelve-month figure through Mar 2026 was $4.2 billion (up 132.7% YoY), and the FY2025 annual result was -$295.0 million, up 95.95% from the prior year.
• Change in Cash advanced to $4.2 billion in Q1 2026 per ABBV's latest filing, from -$400.0 million in the prior quarter.
• Over five years, Change in Cash peaked at $5.3 billion in Q1 2024 and troughed at -$5.9 billion in Q3 2024.
• A 5-year average of -$20.9 million and a median of -$400.0 million in 2025 frame the typical range for Change in Cash.
• The sharpest annual moves came in 2022 and 2026: Change in Cash sank 379.33% in 2022, then soared 1292.55% in 2026.
• A 5-year view of Change in Cash shows it stood at -$2.6 billion in 2022, then jumped by 82.02% to -$473.0 million in 2023, then slumped by 266.38% to -$1.7 billion in 2024, then soared by 76.92% to -$400.0 million in 2025, then soared by 1140.5% to $4.2 billion in 2026.
• Business Quant data shows ABBV's Change in Cash at $4.2 billion in Q1 2026, -$400.0 million in Q4 2025, and -$838.0 million in Q3 2025.